SCHEMBL7698765

SCHEMBL7698765

COc1c(CC(=O)O)c2ccccc2n1Cc1ccc(Cl)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.57
MEN1 O00255 2/20 0.57
LMNA P02545 2/20 0.57
KMT2A Q03164 2/20 0.57
CYP1A2 P05177 2/20 0.57
CYP3A4 P08684 2/20 0.57
CYP2C9 P11712 2/20 0.57
CYP2C19 P33261 2/20 0.57
RGS12 O14924 1/20 0.57
MAPT P10636 1/20 0.57
PKM P14618 1/20 0.57
TSHR P16473 1/20 0.57
NFKB1 P19838 1/20 0.57
MAPK1 P28482 1/20 0.57
GNAI1 P63096 1/20 0.57
PMP22 Q01453 1/20 0.57
HIF1A Q16665 1/20 0.57
PTGDR2 Q9Y5Y4 4/20 0.54
PTGES O14684 1/20 0.52
ALOX5 P09917 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4209387 0.84 PTGDR2 (0.74) ALDH1A1MEN1LMNAKMT2ACYP1A2
SCHEMBL9585134 0.76 PTGDR2 (0.49) ALDH1A1MEN1LMNAKMT2ACYP1A2
SCHEMBL13802422 0.74 PTGDR2 (0.76) ALDH1A1MEN1LMNAKMT2ACYP1A2
SCHEMBL4270126 0.73 THRA (0.71) ALDH1A1MEN1LMNAKMT2ACYP1A2
SCHEMBL1322507 0.73 LMNA (1.00) ALDH1A1MEN1LMNAKMT2ACYP1A2
SCHEMBL9584740 0.73 TP53 (0.56) ALDH1A1MEN1LMNAKMT2ACYP1A2
SCHEMBL8167328 0.73 MEN1 (0.52) ALDH1A1MEN1LMNAKMT2APTGDR2
SCHEMBL4211522 0.72 PTGDR2 (0.72) ALDH1A1MEN1LMNAKMT2ACYP1A2
SCHEMBL11459495 0.72 ALDH1A1 (0.56) ALDH1A1MEN1LMNAKMT2ACYP1A2
SCHEMBL4266132 0.72 FOLH1 (0.63) ALDH1A1MEN1LMNAKMT2APTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002020478-A1 N-BENZYLINDOLE-3-ACETIC ACID DERIVATIVES FOR USE IN THE TREATMENT OF DRUG RESISTAN CANCER DUBLIN CITY UNIVERSITY (IE) 2002-03-14 WO disclosed